Skip to content

DrugFor™

by Vitrosens Biotechnology Inc. 12 variants

Ref VDDOA10R4S50, VDDOA10

DrugFor™ (VDDOA10R4S50) is a device classified as Class B (EU), IVD General (EU) made by Vitrosens Biotechnology Inc., registered in EUDAMED on 1 Oct 2026 (Basic UDI-DI 868354825VDDOA102L), active as of 25 Oct 2026.

Active European Union

CE IVDR CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD Number868354825VDDOA102L Basic UDI-DI 08684998272704UDI-DIDate1 Oct 2026RegisteredStatusActive
European UnionCE/IVDR Number868354825VDDOA102L Basic UDI-DI 08684998272704UDI-DIDate1 Oct 2026RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD, CE/IVDR Active

Specification

EUDAMED

Device name
Buprenorphine (BUP) Test Kit (Urine)
Model / reference
VDDOA10R4S50, VDDOA10
Primary DI / UDI-DI
08684998272704
Basic UDI-DI
868354825VDDOA102L, B-08684998272704
EMDN code
W0102090117 Buprenorphine
Device class
Class B
Class IVD General
EU registration type
Standard device
Legacy device (under a directive)
EU market of registration
Türkiye

Manufacturer details

EUDAMED SRN
TR-MF-000026452

Similar devices in this category

Other devices filed under BUPRENORPHINE.

Other devices from Vitrosens Biotechnology Inc.

See all devices from Vitrosens Biotechnology Inc. →

Properties

  • Reagent
  • IVD kit
  • Professional testing
Other properties (10, all answered No)